Jane Street Group LLC Makes New $357,000 Investment in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Jane Street Group LLC bought a new position in BlackRock Health Sciences Term Trust (NYSE:BMEZ) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 22,524 shares of the company’s stock, valued at approximately $357,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Sessa Capital IM L.P. boosted its stake in BlackRock Health Sciences Term Trust by 27.1% in the second quarter. Sessa Capital IM L.P. now owns 1,853,022 shares of the company’s stock worth $28,462,000 after buying an additional 395,288 shares in the last quarter. Almitas Capital LLC boosted its stake in BlackRock Health Sciences Term Trust by 89.3% in the second quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock worth $27,063,000 after buying an additional 831,025 shares in the last quarter. Penserra Capital Management LLC purchased a new stake in BlackRock Health Sciences Term Trust in the third quarter worth approximately $15,390,000. Stifel Financial Corp boosted its stake in BlackRock Health Sciences Term Trust by 2.2% in the third quarter. Stifel Financial Corp now owns 414,346 shares of the company’s stock worth $6,563,000 after buying an additional 8,843 shares in the last quarter. Finally, Sanctuary Advisors LLC purchased a new stake in BlackRock Health Sciences Term Trust in the second quarter worth approximately $3,179,000.

BlackRock Health Sciences Term Trust Stock Up 1.9 %

Shares of BMEZ opened at $15.51 on Thursday. BlackRock Health Sciences Term Trust has a 1 year low of $14.27 and a 1 year high of $16.59. The stock has a 50 day simple moving average of $15.31 and a two-hundred day simple moving average of $15.57.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, January 31st. Shareholders of record on Wednesday, January 15th will be issued a $0.1782 dividend. The ex-dividend date of this dividend is Wednesday, January 15th. This represents a $2.14 dividend on an annualized basis and a yield of 13.79%.

Insiders Place Their Bets

In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. acquired 29,795 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Wednesday, October 16th. The stock was bought at an average cost of $15.81 per share, for a total transaction of $471,058.95. Following the acquisition, the insider now owns 20,750,913 shares of the company’s stock, valued at $328,071,934.53. This represents a 0.14 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.